https://www.selleckchem.com/pr....oducts/danirixin.htm
001), disease severity (P less then 0.001), and likelihood of mortality (P less then 0.001). There were no differences in length of stay, mortality, or total costs between the HM and POEM groups. Patients hospitalized with achlasia increased from 2013 to 2017, possibly due to the growth and accessibility of high-resolution esophageal manometry. As expertise in POEM increases, the number of POEM performed is anticipated to rise with possible further reductions in other treatment modalities for achalasia.Two frequently encountered b